shareholder lawsuit

The Gross Law Firm reminds Lufax Holding Ltd investors of May 20, 2026 deadline to join securities class action alleging false statements and control failures.

$HTGC securities lawsuit alleges false statements on due diligence, loan origination, and portfolio valuation. Lead plaintiff deadline: May 19, 2026.

Class action firm investigates Esperion Therapeutics' $3.16-per-share ARCHIMED sale, questioning deal fairness to shareholders.

The Gross Law Firm filed a securities class action against $GLOB for allegedly misrepresenting Latin American operations as stable while facing declining demand and wage freezes.

Law firm investigates $SES for potential securities fraud after stock plunged 36.8% following disappointing 2026 revenue guidance and prior allegations of customer losses.

Law firm investigates Sportradar after Muddy Waters report alleges illegal gambling facilitation; stock falls 23% as securities violations reviewed.

Monteverde & Associates investigates XOMA Royalty's $39-per-share sale to Ligand Pharmaceuticals, questioning whether terms are fair to shareholders.

Schall Law Firm launches fraud investigation into Nano-X Imaging ($NNOX) following $17.5M impairment charge and CFO departure that triggered 25% stock decline.

Shareholders sue Atara Biotherapeutics for allegedly misleading statements on manufacturing issues and failed ALLELE study data affecting tabelecleucel approval prospects.

Corcept Therapeutics ($CORT) faces securities lawsuit over alleged false FDA statements on relacorilant. Lead plaintiff deadline: April 21, 2026.

Class action lawsuit filed against $IT over alleged misleading growth projections. Stock fell 27.55% and 20.87% after earnings misses. Lead plaintiff deadline May 18, 2026.

Driven Brands ($DRVN) plummets 33% after announcing material financial misstatements requiring restatement. Securities class action expanded; $900M market cap erased.

Kaskela Law investigates Priority Technology Holdings ($PRTH) for alleged securities violations as stock falls 33% from $7.50 to $5.00 since October 2025.

Monteverde & Associates investigates four merger transactions including Masimo's $180/share Danaher sale, with shareholder votes scheduled for May 1, 2026.

TruBridge disclosed accounting errors preventing timely 2025 Annual Report filing, triggering 10.5% stock decline and securities investigation by Kirby McInerney LLP.

The Gross Law Firm filed a class action lawsuit against uniQure N.V. for allegedly making false statements about FDA approval and BLA timeline prospects.

Coty faces securities fraud investigation after Q2 miss, 200bp margin compression, and full guidance withdrawal. Stock plunged 15.56% to $2.66.

Law firm investigates $STLA for potential securities violations following €22.2B charge announcement that crashed stock 23.7% in single day.

The Gross Law Firm launched a class action lawsuit against Paysafe ($PSFE) alleging materially false statements about ecommerce exposure and merchant risks during 2025.

Kyndryl Holdings faces securities class action lawsuit alleging materially false statements and inadequate internal controls. Lead plaintiff deadline set for April 13, 2026.